Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 20 May 2024 for Replimune Group, Inc., €68k. Read the official filing
Filing timeline
BuySaleRobert Coffin
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert Coffin: trading record in brief
All filings by Robert Coffin on record concern Replimune Group, Inc., in the capacity of chief executive. In total, 7 filings cover trades dated from 28 June 2021 to 16 May 2024.
No open-market purchase appears, only 5 sales worth €1.0M. The rest of the record consists of 2 share grants. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 20 May 2024: an open-market sale of €68k, in Replimune Group, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Coffin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,464 shares@ US$6.473.8% of flowCommon StockSEC:0001104659-24-063560:0
7,861 shares@ US$18.057.3% of flowCommon StockSEC:0001104659-23-062377:0
45,000 shares0Common StockSEC:0001104659-23-041718:0
5,737 shares@ US$14.597.7% of flowCommon StockSEC:0001104659-22-062606:0
26,250 shares0Common StockSEC:0001104659-22-042771:0
7,810 shares@ US$40.0425.5% of flowCommon StockSEC:0001104659-21-089919:0
14,663 shares@ US$40.0447.5% of flowCommon StockSEC:0001104659-21-087803:0
7 of 7 declarations
